← All Sponsors
SPONSOR

Chongqing Peg-Bio Biopharm Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Primary Immune Thrombocytopenia (ITP)
NCT06880081 Phase 1
Recruiting

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Primary Immune Thrombocytopenia (ITP)
China View Trial →